StockNews.com began coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research report sent to investors on Wednesday morning. The firm issued a hold rating on the biopharmaceutical company’s stock.
Athersys Price Performance
Athersys has a 52 week low of $0.01 and a 52 week high of $1.99. The company has a market capitalization of $833,000.00, a price-to-earnings ratio of -0.01 and a beta of -0.90.
Athersys Company Profile
Further Reading
- Five stocks we like better than Athersys
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Analysts Lift Archer Aviation Stock Despite Earnings Miss
- What Are Earnings Reports?
- 5 Best Gold ETFs for March to Curb Recession Fears
- ESG Stocks, What Investors Should Know
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.
